Repligen (NASDAQ:RGEN), a bioprocessing technology company ... but in line with the 20.9% result it achieved in Q4. Moreover, it guided for adjusted EPS of between $1.67 and $1.76, up from ...
EPS: $0.15 in Q4 vs. -$0.05 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
EPS: $1.24 in Q4 vs. -$3.23 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
EPS: -$1.00 in Q4 vs. $0.48 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
EPS: $0.08 in Q4 vs. -$0.07 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
EPS: -$0.02 in Q4 vs. $0.76 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
EPS: $0.33 in Q4 vs. -$0.15 in the same period last year ... opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Online insurance comparison site EverQuote (NASDAQ:EVER) reported in Q4 CY2024, with sales up 165% year on year to $147.5 ...
$127.4 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...
$339.19 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...
$512.3 Mln last year. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...